Dr Reddys Laboratories (RDY) Operating Income Growth (5y) (2014 - 2023)
Dr Reddys Laboratories (RDY) Operating Income Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.19 Bn | 87.33 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.22 Bn | 21.07 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.81 Bn | 9.64 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 25.16% |
| Mar 31, 2023 | 26.29% |
| Dec 31, 2022 | 31.09% |
| Sep 30, 2022 | 1,818.26% |
| Mar 31, 2021 | -4.83% |
| Sep 30, 2020 | -21.99% |
| Jun 30, 2020 | -4.16% |
| Sep 30, 2019 | -21.04% |
| Mar 31, 2019 | 0.73% |
| Dec 31, 2018 | -9.09% |
| Sep 30, 2018 | -9.93% |
| Jun 30, 2018 | -60.59% |
| Mar 31, 2018 | -1.17% |
| Dec 31, 2017 | -22.11% |
| Sep 30, 2017 | -11.01% |
| Dec 31, 2016 | -54.88% |
| Sep 30, 2016 | -61.97% |
| Mar 31, 2016 | 12.59% |
| Dec 31, 2015 | 1.36% |
| Sep 30, 2015 | 23.36% |